Require drug manufacturers and pharmacy benefit managers to disclose pricing information for prescription medications.
One policy goal, tracked across every bill that has carried it.
What’s happening with Prescription Drug Supply Chain Pricing Transparency Act?
The Prescription Drug Supply Chain Pricing Transparency Act is currently in the Senate Committee on Finance as of January 28, 2026. The committee members must hold a vote to move the bill forward, but most bills fail to receive a committee vote and die in this stage. No action has occurred on this legislation since January 28, 2026.
Updated July 9, 2026 · Generated by AI. Always verify with official sources.
Where it stands
Now carried by Prescription Drug Supply Chain Pricing Transparency Act (S. 3751 (119th)) →
Legislative Progress
How we got here
Every bill that has carried this goal, oldest first.
Died with Congress · Jan 3, 2025
Died when the 118th Congress ended without final passage. Bills must be reintroduced under a new number to be revived.
Reintroduced · Jan 3, 2025
Reintroduced from S. 2198 (118th), which died when its Congress ended.
S. 2198 (118th) →
Vehicles
Who’s behind it
Michael Bennet (D-CO)Wrote and sponsored the current bill.